• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program

    Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program

  2. Veracyte to Present at JMP Securities 2014 Healthcare Conference

    Veracyte to Present at JMP Securities 2014 Healthcare Conference

  3. Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)

    Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)

  4. Early Favorites for Manager of the Year--Domestic Stock

    Who's in front heading 'round the bend?

  5. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

  6. High-Confidence Stock Picks

    Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.

  7. Back to Basics

    This screen finds stocks that would make it into Morningstar's Wide-Moat Focus strategy.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.